-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.↓
Börse NYSE New York Stock ExchangeISIN US58933Y1055-
Merck & Co.Börse NYSE New York Stock ExchangeISIN US58933Y1055 WKN: A0YD8QSymbol MRK
-
Merck & Co.Börse Xetra FrankfurtISIN US58933YAW57EURSymbol 6MK
-
MERCK & CO. INC.Börse Börse DüsseldorfEURSymbol 6MK
-
MERCK & CO. INC.Börse Börse HamburgEURSymbol 6MK
-
MERCK & CO. INC.Börse Börse BerlinEURSymbol 6MK
-
MERCK & CO. INC.Börse Gettex System der Börse MünchenEURSymbol 6MK
-
MERCK & CO. INC.Börse Tradegate System der Deutsche Börse AG (60%)EURSymbol 6MK
-
MERCK & CO. INC.Börse Börse StuttgartEURSymbol 6MK
-
MERCK & CO. INC.Börse Börse MünchenEURSymbol 6MK
-
MERCK & CO. INC.Börse Börse FrankfurtEURSymbol 6MK
-
MERCK & CO. INC.Börse Quotrix System der Börse DüsseldorfEURSymbol 6MK
-
Merck & Co.Börse BUEUSDISIN US58933Y1055
-
USDISIN US58933YAT29
-
MXNISIN US58933YAR62
-
USD
-
EUR
-
ISIN US58933Y1055
WKN A0YD8Q
Symbol MRK
Börse
NYSE New York Stock Exchange Zeitzone: America/Argentina/Buenos_Aires
Marktkapitalisierung
150.086.000.000
Mitarbeiter
67.000
Aktionärsstruktur der Merck & Co.
Entdecke die 6 ETFs in denen Merck & Co. am höchsten gewichtet ist Insgesamt in 31 ETFs enthalten
Dir gefallen die Informationen zu Merck & Co.?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
Dir gefallen die Informationen zu Merck & Co.?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
Dir gefallen die Informationen zu Merck & Co.?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
Dir gefallen die Informationen zu Merck & Co.?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
256 News & Informationen zur Merck & Co. Aktie
Company Of The Day: Merck
The U.S. FDA approved a new version of Merck's (NYSE:MRK) pneumococcal vaccine that prevents invasive disease caused by 15 strains of bacteria called Streptococcus pneumoniae…
Global Monoclonal Antibodies Market is Expected to Reach $390.58 Billion by 2030: Says AMR
Increase in prevalence of various cancer types, rise in demand for cost-efficient biosimilar monoclonal antibodies, and upsurge in likelihood of epidemic…
Diabetic Nephropathy Market Report 2021-2028 | Size, Share, Growth, Trends, Competitive Landscape, Revenue, Analysis, Forecast Report
Top Players Covered in the Diabetic Nephropathy Market Research Report are Merck & Co., Inc., Abbott, Pfizer Inc., Siemens, Novartis AG, GENERAL ELECTRIC…
Allied Investment Advisors, LLC Buys Pfizer Inc, Merck Inc, Lockheed Martin Corp, Sells Southwest Airlines Co, Inovio Pharmaceuticals Inc
GuruFocus Article or News written by insider and the topic is about:
Merck (MRK) Gains As Market Dips: What You Should Know
Merck (MRK) closed the most recent trading day at $78.02, moving +0.15% from the previous trading session.
Merck : Announces U.S. FDA Approval of VAXNEUVANCE™ (Pneumococcal 15-valent Conjugate Vaccine) for the Prevention of Invasive Pneumococcal Disease in Adults 18 Years and Older Caused by 15 Serotypes
Clinical Data Supporting Approval Demonstrated Non-Inferior Immune Responses for the Serotypes Shared with PCV13
VAXNEUVANCE Elicited Superior Immune Responses for Serotypes 3, 22F and 33F… | July 16, 2021
Music industry ponders change of tune on streaming rewards
UK politicians call for radical overhaul aimed at putting more money in artists’ pockets
Novartis, Eli Lilly and AbbVie Top 5-Year New Drug Productivity List
GuruFocus Article or News written by Barry Cohen and the topic is about: Bristol-Myers is last with just 3 novel medicines brought to market
10 Best Blue Chip Dividend Stocks Hedge Funds Are Buying
In this article, we will be looking at the 10 best blue chip dividend stocks hedge funds are buying. To skip our detailed analysis of blue-chip stocks…
3 Stocks To Buy In A 'Risk-Off' Market
Stocks Analysis by MarketBeat.com (Sean Sechler) covering: Coca-Cola Co, Merck & Company Inc, Colgate-Palmolive Company, Duke Energy Corporation. Read MarketBeat.com (Sean Sechler)'s latest article on Investing.com
Stolper Co Buys Alibaba Group Holding, The Kroger Co, Merck Inc, Sells Caterpillar Inc, Target Corp, Brookfield Real Assets Income Fund
GuruFocus Article or News written by insider and the topic is about:
2 Top Stocks to Buy and Hold in Your RRSP
While aiming for growth and enjoying tax-deferred investment in your RRSP, you should consider these two types of top stocks.
At a CAGR of 9.8%, Animal Disinfectant Market to Surpass US$ 7477.4 Million globally by 2028, Says Coherent Market Insights (CMI)
SEATTLE, July 15, 2021 (GLOBE NEWSWIRE) — According to Coherent Market Insights, the global animal disinfectant market is estimated to be valued at US$…
Sather Financial Group Inc Buys Pilgrims Pride Corp, Aerojet Rocketdyne Holdings Inc, Nuance Communications Inc, Sells Amazon.com Inc, Prosperity Bancshares Inc, Merck Inc
GuruFocus Article or News written by insider and the topic is about:
Advaxis to Present at the Non-Small Cell Lung Cancer Drug Development Summit
PRINCETON, N.J., July 14, 2021 (GLOBE NEWSWIRE) — Advaxis, Inc. (Nasdaq: ADXS), a clinical-stage biotechnology company focused on the development and…
6 Meridian Buys VanEck Vectors J.P. Morgan EM Local Currency Bond , iShares 3-7 Year Treasury Bond ETF, iShares 20+ Year Treasury Bond ETF, Sells Vanguard Short-Term Government Bond ETF, First Trust L
GuruFocus Article or News written by insider and the topic is about:
Parnassus Endeavor Fund Buys 5 Stocks in 2nd Quarter
GuruFocus Article or News written by Margaret Moran and the topic is about: Socially responsible fund focuses more on health care with several new buys
Goldman Sachs Names Merck, Mettler and IDEXX Attractive Health Care Stocks
GuruFocus Article or News written by Barry Cohen and the topic is about: Others to make the industry list are Abbott, Agilent and Cerner
Rising Demand For Needle-free Vaccines To Drive Innovation In The Respiratory Virus Vaccines Market, TMR
ALBANY, N.Y., July 13, 2021 /PRNewswire/ — A vaccination refers to a biological product that is utilized to provide acquired immunity against a variety of
Rising Demand for Needle-free Vaccines to Drive Innovation in the Respiratory Virus Vaccines Market, TMR
/PRNewswire/ — A vaccination refers to a biological product that is utilized to provide acquired immunity against a variety of infections that can be…
American National Bank Buys Goldman Sachs ActiveBeta International Equity ETF, Fidelity MSCI Information Technology Index ETF, Fiserv Inc, Sells Target Corp, UnitedHealth Group Inc, Cummins Inc
GuruFocus Article or News written by insider and the topic is about:
Hexavest Inc. Buys Cardinal Health Inc, iShares MSCI China ETF, Consolidated Edison Inc, Sells VanEck Vectors Gold Miners ETF, VanEck Vectors Junior Gold Miners ETF, Eli Lilly and Co
GuruFocus Article or News written by insider and the topic is about:
An Improving Economy Bodes Well for Veteran Employment
Photo by Aaron Burden on Unsplash
With the pandemic easing in the U.S., the economy seems to be moving in the right direction. And while job …
10 Stocks Warren Buffett is Selling
In this article, we discuss the 10 stocks Warren Buffett is selling. You can skip our detailed discussion on Buffett's history, investment philosophy,…
NeuroBo Pharmaceuticals' : Shareholders Elect Hyung Heon Kim and Andrew I. Koven to NeuroBo's Board of Directors
BOSTON, July 12, 2021 /PRNewswire/ — NeuroBo Pharmaceuticals, Inc. , a clinical-stage biotechnology company focused on developing and commercializing multimodal disease-modifying therapies for… | July 12, 2021
Renovacor Announces the Appointment of Jiwen Zhang, Ph.D., as Senior Vice President, Regulatory Affairs and Quality Assurance
Dr. Zhang has over 20 years of experience in regulatory affairs, with over a decade specifically in the field of cell and gene therapy…
Merck : Interim Results from Phase 2/3 Studies of Molnupiravir, an Investigational Oral Antiviral Therapeutic for Mild to Moderate COVID-19, Presented at the European Congress of Clinical Microbiology
Merck , known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics announced today the presentation of previously announced Phase 2 interim results from two Phase 2/3 clinical… | July 12, 2021
Global Tax Rate Debate: How Does Mega-Cap Tech Stack Up?
Stocks Analysis by Brian Gilmartin covering: S&P 500, Intel Corporation, Microsoft Corporation, Merck & Company Inc. Read Brian Gilmartin's latest article on Investing.com
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 1.30% By Investing.com
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 1.30%
Disney And Goldman Sachs Lead The DIA Higher Friday
U.S. indices were trading higher Friday as markets rebound following a sell-off yesterday over concerns the economic recovery is slowing as the COV…
Nabriva Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
DUBLIN, Ireland, July 09, 2021 (GLOBE NEWSWIRE) — Nabriva Therapeutics plc NBRV, a biopharmaceutical company engaged in the commercialization and development
Global Animal Pharmaceuticals Market Report 2021-2026
DUBLIN, July 9, 2021 /PRNewswire/ — The 'Global Animal Pharmaceuticals Market, By Product Type (Drugs, Vaccine, Medicated Feed), By Animal Type, …
Global Animal Pharmaceuticals Market Report 2021-2026
/PRNewswire/ — The “Global Animal Pharmaceuticals Market, By Product Type (Drugs, Vaccine, Medicated Feed), By Animal Type, By Route of Administration, By…
Mid-Morning Market Update: Markets Open Higher; AZZ Reports Upbeat Q1 Results
Following the market opening Friday, the Dow traded up 1.10% to 34,799.54 while the NASDAQ rose 0.63% to 14,651.61. The S&P also rose, gaining 0.84% to …
Active Pharmaceutical Ingredients Market Worth USD 312 Billion by 2028 at 6.2% CAGR – Report by Market Research Future (MRFR)
Active Pharmaceutical Ingredients Market Insights and Industry Analysis by Type of Synthesis (Biotech and Synthetic), By Molecules (Large Molecule and…
Global Stress Management Market Size to Grow at a CAGR of 3.5% from 2021 to 2030
The global stress management market reached USD 18,600.9 million in 2020 and is projected to grow at a CAGR of 3.5% during the forecast period. Based on…
Global Stress Management Market Size to Grow at a CAGR of 3.5% from 2021 to 2030
The global stress management market reached USD 18,600.9 million in 2020 and is projected to grow at a CAGR of 3.5% during the forecast period. Based on…
Global Stress Management Market Size to Grow at a CAGR of 3.5% from 2021 to 2030
The global stress management market reached USD 18,600.9 million in 2020 and is projected to grow at a CAGR of 3.5% during the forecast period. Based on…
Global Stress Management Market Size to Grow at a CAGR of 3.5% from 2021 to 2030
The global stress management market reached USD 18,600.9 million in 2020 and is projected to grow at a CAGR of 3.5% during the forecast period. Based on…
Global Stress Management Market Size to Grow at a CAGR of 3.5% from 2021 to 2030
The global stress management market reached USD 18,600.9 million in 2020 and is projected to grow at a CAGR of 3.5% during the forecast period. Based on…